News Comparing Anti-VEGF Agents for Neovascular AMD by Medscape • 2012/10/15 • 0 Comments How do ranibizumab and bevacizumab compare in the treatment of neovascular AMD? The 2-year follow-up results from CATT are in. Medscape Ophthalmology Full Story →